<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Russian Journal of Immunology</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17517</article-id><article-id pub-id-type="doi">10.46235/1028-7221-17517-IAI</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Interleukin-6 and interleukin-8 as immunological markers of acute pyelonephritis activity in children</article-title><trans-title-group xml:lang="ru"><trans-title>Интерлейкин-6 и интерлейкин-8 как иммунологические маркеры активности острого пиелонефрита у детей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nurmatova</surname><given-names>N. F.</given-names></name><name xml:lang="ru"><surname>Нурматова</surname><given-names>Н. Ф.</given-names></name></name-alternatives><address><country country="UZ">Uzbekistan</country></address><bio xml:lang="ru"><p>д.м.н., доцент кафедры пропедевтики детских болезней № 1</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Associate Professor, Department of Propaedeutics of Children’s Diseases No. 1</p></bio><email>nargiza-nurmatova78@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khabibulloeva</surname><given-names>B. R.</given-names></name><name xml:lang="ru"><surname>Хабибуллоева</surname><given-names>Б. Р.</given-names></name></name-alternatives><address><country country="UZ">Uzbekistan</country></address><bio xml:lang="ru"><p>ассистент кафедры пропедевтики детских болезней № 1</p></bio><bio xml:lang="en"><p>Assistant Professor, Department of Propaedeutics of Children’s Diseases No. 1</p></bio><email>nargiza-nurmatova78@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Tashkent State Medical University</institution></aff><aff><institution xml:lang="ru">Ташкентский государственный медицинский университет</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-11-01"><day>01</day><month>11</month><year>2026</year></pub-date><pub-date date-type="collection"><year>2026</year></pub-date><volume>29</volume><issue>4</issue><issue-title xml:lang="ru"/><issue-title xml:lang="en"/><fpage>1131</fpage><lpage>1136</lpage><history><date date-type="received" iso-8601-date="2026-04-25"><day>25</day><month>04</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-07-30"><day>30</day><month>07</month><year>2026</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2026-04-25"><day>25</day><month>04</month><year>2026</year></date></event-desc></event><event event-type="accepted"><event-desc>Accepted:<date date-type="accepted" iso-8601-date="2026-07-30"><day>30</day><month>07</month><year>2026</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-11-01"><day>01</day><month>11</month><year>2026</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Nurmatova N.F., Khabibulloeva B.R.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Нурматова Н.Ф., Хабибуллоева Б.Р.</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Nurmatova N.F., Khabibulloeva B.R.</copyright-holder><copyright-holder xml:lang="ru">Нурматова Н.Ф., Хабибуллоева Б.Р.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/17517">https://rusimmun.ru/jour/article/view/17517</self-uri><abstract xml:lang="en"><p>Acute pyelonephritis in children is an important issue in pediatrics, pediatric nephrology and clinical immunology, since the disease is associated with the risk of renal parenchymal affection, recurrent course and development of functional renal disorders. The aim of the study was to assess serum levels of IL-6 and IL-8 in children with acute pyelonephritis and to determine their diagnostic significance as immunological markers of infectious/inflammatory process activity. A total of 68 children with acute pyelonephritis aged 3 to 15 years were examined. The control group included 30 apparently healthy children of comparable age who underwent preventive examination. The diagnosis was based on complaints, medical history, clinical manifestations, complete blood counts, urinalysis, bacteriological urine examination and ultrasound examination of the urinary system. Serum levels of IL-6 and IL-8 were determined by ELISA technique. The results were presented as M ± m, and statistical significance was assessed at p &lt; 0.05. In children with acute pyelonephritis, fever was observed in 58 patients (85.3%); intoxication syndrome, in 54 patients (79.4%); leukocyturia, in 63 patients (92.6%); bacteriuria, in 49 patients (72.1%). The mean level of IL-6 in the main group was significantly higher than in apparently healthy children being increased to 28.6 ± 2.4 pg/mL <italic>versus</italic> 7.8 ± 0.9 pg/mL, respectively (p &lt; 0.001). The concentration of IL-8 was also significantly increased: 44.3 ± 3.6 pg/mL in the main group <italic>versus</italic> 12.5 ± 1.4 pg/mL in the control group (p &lt; 0.001). In children with pronounced fever and intoxication syndrome, IL-6 and IL-8 levels were higher than in patients with less severe disease activity. The obtained data indicate that acute pyelonephritis in children is accompanied by activation of systemic and local cytokine responses. Increased IL-6 reflects the severity of the systemic inflammatory reaction, whereas increased IL-8 is associated with neutrophilic activation and local inflammation in the urinary system. IL-6 and IL-8 may be considered additional immunological criteria for assessing the activity of acute pyelonephritis in children.</p></abstract><trans-abstract xml:lang="ru"><p>Острый пиелонефрит у детей является одной из значимых проблем педиатрии, детской нефрологии и клинической иммунологии, поскольку заболевание сопровождается риском поражения почечной паренхимы, рецидивирующего течения и формирования функциональных нарушений почек. Цель исследования – оценить уровни IL-6 и IL-8 у детей с острым пиелонефритом и определить их диагностическую значимость как иммунологических маркеров активности инфекционно-воспалительного процесса. Обследованы 68 детей с острым пиелонефритом в возрасте от 3 до 15 лет. Контрольную группу составили 30 практически здоровых детей сопоставимого возраста, проходивших профилактическое обследование. Диагноз устанавливался на основании жалоб, анамнеза, клинической картины, данных общего анализа крови, общего анализа мочи, бактериологического исследования мочи и ультразвукового исследования органов мочевой системы. Уровни IL-6 и IL-8 в сыворотке крови определяли методом иммуноферментного анализа. Результаты представлены в виде M ± m, статистическую значимость различий оценивали при p &lt; 0,05. У детей с острым пиелонефритом лихорадка отмечалась у 58 пациентов (85,3%), интоксикационный синдром – у 54 (79,4%), лейкоцитурия – у 63 (92,6%), бактериурия – у 49 (72,1%). Уровень IL-6 у детей основной группы был достоверно выше, чем у практически здоровых детей, и составил 28,6 ± 2,4 пг/мл против 7,8 ± 0,9 пг/мл соответственно (p &lt; 0,001). Концентрация IL-8 также была достоверно повышена: 44,3 ± 3,6 пг/мл в основной группе против 12,5 ± 1,4 пг/мл в контрольной группе (p &lt; 0,001). У детей с выраженной лихорадкой и интоксикационным синдромом показатели IL-6 и IL-8 были выше, чем при менее выраженном течении заболевания. Полученные данные свидетельствуют, что острый пиелонефрит у детей сопровождается активацией системного и локального цитокинового ответа. Повышение IL-6 отражает выраженность системной воспалительной реакции, тогда как увеличение IL-8 связано с нейтрофильной активацией и локальным воспалением в мочевой системе. IL-6 и IL-8 могут рассматриваться как дополнительные иммунологические критерии активности острого пиелонефрита у детей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>acute pyelonephritis</kwd><kwd>children</kwd><kwd>IL-6</kwd><kwd>IL-8</kwd><kwd>cytokines</kwd><kwd>immunological markers</kwd><kwd>urinary tract infection</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>острый пиелонефрит</kwd><kwd>дети</kwd><kwd>IL-6</kwd><kwd>IL-8</kwd><kwd>цитокины</kwd><kwd>иммунологические маркеры</kwd><kwd>инфекция мочевых путей</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Дустбабаева Н.Д., Ирсалиева Ф.Х., Нурматова Н.Ф., Байбекова В.Ф., Айдарова Н.П., Ахмедов Х.С. Полиморфизм rs2275913 гена IL17A в узбекской популяции и его связь с развитием аллергического ринита // Российский иммунологический журнал, 2020. Т. 23, № 4. С. 443-448. [Dustbabaeva N.D., Irsaliyeva F. Kh., Nurmatova N.F., Baybekova V.F., Aydarova N.P., Akhmedov Kh.S. IL17A rs2275913 gene polymorphism in Uzbek ethnic group and its linkage with development of allergic rhinitis. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2020, Vol. 23, no. 4, pp. 443-448. (In Russ.)] doi: 10.46235/1028-7221-450-IGP.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ирсалиева Ф.Х., Дустбабаева Н.Д., Камалов З.С., Зиядуллаев Ш.Х., Нурматова Н.Ф., Aхмедов Ж.Х. Полиморфизм IL17A rs2275913 и особенности иммунологических показателей у больных персистирующим аллергическим ринитом при проведении аллерген-специфической терапии // Российский иммунологический журнал, 2020. Т. 23, № 4. C. 449-460. [Irsalieva F.Kh., Dustbabaeva N.D., Kamalov Z.S., Ziyadullaev Sh.Kh., Nurmatova N.F., Akhmedov Zh.Kh. IL17A rs2275913 polymorphism and features of immunological parameters in patients with persistent allergic rhinitis during allergen-specific immunotherapy. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2020, Vol. 23, no. 4, pp. 449-460. (In Russ.)] doi: 10.46235/1028-7221-440-IPA.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Benson M., Jodal U., Andreasson A., Karlsson A., Rydberg J., Svanborg C. Interleukin-6 response to urinary tract infection in childhood. Pediatr. Infect. Dis. J., 1994, Vol. 13, no. 7, pp. 612-616.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Godaly G., Proudfoot A.E., Offord R.E., Svanborg C., Agace W.W. Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration. Infect. Immun., 1997, Vol. 65, no. 8, pp. 3451-3456.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Hedges S., Svanborg C. The mucosal cytokine response to urinary tract infections. Int. J. Antimicrob. Agents, 1994, Vol. 4, no. 2, pp. 89-93.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Hosseini M., Ahmadzadeh H., Toloui A., Ahmadzadeh K., Madani Neishaboori A., Rafiei Alavi S.N., Gubari M.I.M., Jones M.E., Ataei F., Yousefifard M., Ataei N. The value of interleukin levels in the diagnosis of febrile urinary tract infections in children and adolescents; a systematic review and meta-analysis. J. Pediatr. Urol., 2022, Vol. 18, no. 2, pp. 211-223.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Krzemień G., Szmigielska A., Turczyn A., Pańczyk-Tomaszewska M. Urine interleukin-6, interleukin-8 and transforming growth factor β1 in infants with urinary tract infection and asymptomatic bacteriuria. Cent. Eur. J. Immunol., 2016, Vol. 41, no. 3, pp. 260-267.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Leung A.K.C., Wong A.H.C., Leung A.A.M., Hon K.L. Urinary tract infection in children. Recent Pat. Inflamm. Allergy Drug Discov., 2019, Vol. 13, no. 1, pp. 2-18.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Mahyar A., Ayazi P., Maleki M.R., Daneshi-Kohan M.M., Sarokhani H.R., Hashemi H.J., Talebi-Bakhshayesh M. Serum levels of interleukin-6 and interleukin-8 as diagnostic markers of acute pyelonephritis in children. Korean J. Pediatr., 2013, Vol. 56, no. 5, pp. 218-223.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Maringhini S., Alaygut D., Corrado C. Urinary tract infection in children: an up-to-date study. Biomedicines, 2024, Vol. 12, no. 11, 2582. doi: 10.3390/biomedicines12112582.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Shaikh N., Morone N.E., Bost J.E., Farrell M.H. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr. Infect. Dis. J., 2008, Vol. 27, no. 4, pp. 302-308.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Sheu J.N., Chen M.C., Lue K.H., Cheng S.L., Lee I.C., Chen S.M., Tsay G.J. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine, 2006, Vol. 36, no. 5-6, pp. 276-282.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Simões e Silva A.C., Oliveira E.A. Update on the approach of urinary tract infection in childhood. J. Pediatr. (Rio J.), 2015, Vol. 91, no. 6, Suppl. 1, pp. S2-S10.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Tullus K., Shaikh N. Urinary tract infections in children. Lancet, 2020, Vol. 395, no. 10237, pp. 1659-1668.</mixed-citation></ref></ref-list></back></article>
